VPS9D1

Chr 16

VPS9 domain containing 1

Also known as: ATP-BL, ATPBL, C16orf7

Enables identical protein binding activity. Predicted to be involved in proton motive force-driven ATP synthesis. Predicted to be active in cytosol and endocytic vesicle. [provided by Alliance of Genome Resources, Jul 2025]

OMIMResearchGenerating clinical summary…
LOEUF 1.31
Clinical SummaryVPS9D1
Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?
1.31LOEUF
pLI 0.000
Z-score 0.17
OE 0.97 (0.721.31)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint?
-0.15Z-score
OE missense 1.02 (0.941.11)
364 obs / 356.0 exp
Tolerant

Tolerant to missense variation

Observed / Expected Ratios?
LoF OE?0.97 (0.721.31)
00.351.4
Missense OE?1.02 (0.941.11)
00.61.4
Synonymous OE?1.17
01.21.6
LoF obs/exp: 30 / 31.0Missense obs/exp: 364 / 356.0Syn Z: -1.78

ClinVar Variant Classifications

0 submitted variants in ClinVar

Protein Context — Lollipop Plot

VPS9D1 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →